Marcia G. Yerman: Rheumatoid Arthritis: ChauntÃ© Smith Shares Her Story bi2730574 Rheumatoid arthritis affects 1.3 million Americans, and two to three times more common among women. It a chronic disease that affects the joints, primarily those the hands, wrists, feet, shoulders and knees

FDA to review Pfizer rheumatoid arthritis drug bi2730574 (Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration due to decide on the drug, tofacitinib, August. Pfizer said has also submitted an application for tofacitinib to regulatory authorities Japan. Tofacitinib one of Pfizer's most ..

UCB Announces Start of the EXXELERATE? Clinical Study Rheumatoid Arthritis bi2730574 BRUSSELS , Dec. 21, 2011 /PRNewswire/ -- UCB today announced the start of the EXXELERATE? study evaluate the short- and long-term efficacy of Cimzia® (certolizumab pegol) plus methotrexate (MTX) ..

UCB initiates EXXELERATE study rheumatoid arthritis bi2730574 UCB today announced the start of the EXXELERATE study evaluate the short- and long-term efficacy of Cimzia (certolizumab pegol) plus methotrexate (MTX) compared that of Humira(adalimumab) plus MTX the treatment of moderate to severe rheumatoid arthritis (RA). The start of study confirms previously announced plans

Pfizer: FDA, other countries reviewing application for new type of rheumatoid bi2730574 NEW YORK ? Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted application for approval of experimental drug for adults moderate to severe rheumatoid arthritis. The FDA says expects to rule by August 2012 on the application for tofacitinib (toh-FAH?-sit-eh-nib), Pfizer has touted as a promising new treatment for the autoimmune disease. Read full article ..

TiGenix obtains EUR 2.9 million FP7 grant to fund development of Cx611 rhe bi2730574 Leuven (BELGIUM), Madrid (SPAIN) - December 23, 2011 - TiGenix (NYSE Euronext: TIG), a leading biopharmaceutical company that commercializes and develops cell therapies, announced today that as the coordinator ..

Mindfulness Training May Help Arthritis Patients Cope bi2730574 TUESDAY, Dec. 20 (HealthDay News) -- A small study finds that mindfulness training, teaches people to push away troublesome thoughts, helped improve well-being people rheumatoid arthritis and similar diseases

Who killed Clayton Miller? Nova Scotia family believes police killed son bi2730574 More than two decades after body was discovered a shallow stream New Waterford, N.S., Clayton Miller's family seeking justice ? and an explanation..

Pain Therapeutics - Drugs, Markets and Companies bi2730574 NEW YORK , Dec. 29, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report available catalogue: Pain Therapeutics - Drugs, Markets and Companies http://www.reportlinker.com/p0203548/Pain-Therapeutics---Drugs-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ..

Study linking chronic fatigue syndrome to virus retracted by journal bi2730574 In unusual move, Science's editors retract 2009 study linking virus XMRV to chronic fatigue syndrome..

Jim Cramer Stock Watch: December 21st Stock Picks bi2730574 It's always a good strategy to track transparency of pundits..

Action Date for Pfizer's Tofacitinib bi2730574 With the FDA accepting Pfizer's application for tofacitinib, a response should be out August 2012

Action Date for Pfizer's Tofacitinib - Analyst Blog bi2730574 Pfizer Inc. ( PFE ) recently announced that the new drug application (NDA) for rheumatoid arthritis candidate, tofacitinib, has been accepted by the US Food and Drug Administration..

Remote Access Admin - Home